Publications
Separating the Wheat from the Chaff among HLA-DQ
Endothelium, Inflammation & Allogenicity, J Immunol Apr 22, 2024
Dual chimeric antigen receptor T cells targeting CD38 and SLAMF7 with independent signalling demonstrate preclinical efficacy and safety in Multiple Myeloma.
Lymphocyte development and lymphoid disorders, Cancer Immunol Res. Feb 20, 2024
Single-cell atlas of the liver myeloid compartment before and after cure of chronic viral hepatitis.
T cell immunity in cancers and infectious diseases, Hepatol Sep 20, 2023
Hepatitis-B virus: replication cycle, targets, and antiviral approaches.
T cell immunity in cancers and infectious diseases, Curr Opin Virol. Sep 20, 2023
Endothelial CD34 expression and regulation of immune cell response in-vitro
Endothelium, Inflammation & Allogenicity, Stem cells biotechnologies, Scientific Reports Sep 11, 2023
Circulating T cell profiles associate with enterotype signatures underlying hematological malignancy relapses.
Immune responses in the immunocompromised host, Cell Host Microbe Jun 10, 2023
Distinct subsets of multi-lymphoid progenitors support ontogeny-related changes in human lymphopoiesis.
Lymphocyte development and lymphoid disorders, Stem Cell Reports Jun 8, 2023
System level immune monitoring reveals new pathophysiological features in hepatitis-associated aplastic anemia.
Immune responses in the immunocompromised host, Blood Adv. Jun 2, 2023
Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor.
Lymphocyte development and lymphoid disorders, Blood Mar 16, 2023